Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial.
Article in Psychopharmacology Bulletin (April 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)
Article in International Journal of Molecular Medicine (November 2023)
Markers of muscarinic deficit for individualized treatment in schizophrenia
Article in Frontiers in Psychiatry (January 2023)